Rivastigmine - NDC Database (Page 3)
110 records found
Page:
33342-089 Sep 02, 2014
Rivastigmine Tartrate 1.5 mg Oral Capsule by Macleods Pharmaceuticals Limited
Rivastigmine Tartrate 1.5 mg Oral Capsule by Macleods Pharmaceuticals Limited
33342-091 Sep 02, 2014
Rivastigmine Tartrate 4.5 mg Oral Capsule by Macleods Pharmaceuticals Limited
Rivastigmine Tartrate 4.5 mg Oral Capsule by Macleods Pharmaceuticals Limited
47781-304 Sep 04, 2015
Rivastigmine Transdermal System 4.6 mg Transdermal Patch, Extended Release by Alvogen Inc.
Rivastigmine Transdermal System 4.6 mg Transdermal Patch, Extended Release by Alvogen Inc.
47781-305 Sep 04, 2015
Rivastigmine Transdermal System 9.5 mg Transdermal Patch, Extended Release by Alvogen Inc.
Rivastigmine Transdermal System 9.5 mg Transdermal Patch, Extended Release by Alvogen Inc.
47781-405 Sep 02, 2015
Rivastigmine Transdermal System 13.3 mg Transdermal Patch, Extended Release by Alvogen Inc.
Rivastigmine Transdermal System 13.3 mg Transdermal Patch, Extended Release by Alvogen Inc.
51956-0001 Mar 06, 2019
Rivastigmine 4.6 mg/24h Transdermal Patch, Extended Release by Zydus Technologies Limited
Rivastigmine 4.6 mg/24h Transdermal Patch, Extended Release by Zydus Technologies Limited
51956-0002 Mar 06, 2019
Rivastigmine 9.5 mg/24h Transdermal Patch, Extended Release by Zydus Technologies Limited
Rivastigmine 9.5 mg/24h Transdermal Patch, Extended Release by Zydus Technologies Limited
51956-0003 Mar 06, 2019
Rivastigmine 13.3 mg/24h Transdermal Patch, Extended Release by Zydus Technologies Limited
Rivastigmine 13.3 mg/24h Transdermal Patch, Extended Release by Zydus Technologies Limited
51991-794 Jun 13, 2012
Rivastigmine 3 mg (As Rivastigmine Tartrate 4.8 mg) Oral Capsule by Breckenridge Pharmaceutical, Inc
Rivastigmine 3 mg (As Rivastigmine Tartrate 4.8 mg) Oral Capsule by Breckenridge Pharmaceutical, Inc
51991-795 Jun 13, 2012
Rivastigmine 4.5 mg (As Rivastigmine Tartrate 7.2 mg) Oral Capsule by Breckenridge Pharmaceutical, Inc
Rivastigmine 4.5 mg (As Rivastigmine Tartrate 7.2 mg) Oral Capsule by Breckenridge Pharmaceutical, Inc
51991-796 Jun 13, 2012
Rivastigmine 6 mg (As Rivastigmine Tartrate 9.6 mg) Oral Capsule by Breckenridge Pharmaceutical, Inc
Rivastigmine 6 mg (As Rivastigmine Tartrate 9.6 mg) Oral Capsule by Breckenridge Pharmaceutical, Inc
51991-897 Dec 19, 2019
Rivastigmine Transdermal System Transdermal System 4.6 mg/24h Transdermal Patch, Extended Release by Breckenridge Pharmaceutical, Inc.
Rivastigmine Transdermal System Transdermal System 4.6 mg/24h Transdermal Patch, Extended Release by Breckenridge Pharmaceutical, Inc.
51991-898 Dec 19, 2019
Rivastigmine Transdermal System Transdermal System 9.5 mg/24h Transdermal Patch, Extended Release by Breckenridge Pharmaceutical, Inc.
Rivastigmine Transdermal System Transdermal System 9.5 mg/24h Transdermal Patch, Extended Release by Breckenridge Pharmaceutical, Inc.
51991-899 Dec 19, 2019
Rivastigmine Transdermal System Transdermal System 13.3 mg/24h Transdermal Patch, Extended Release by Breckenridge Pharmaceutical, Inc.
Rivastigmine Transdermal System Transdermal System 13.3 mg/24h Transdermal Patch, Extended Release by Breckenridge Pharmaceutical, Inc.
Page:
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.